Member of the Association of American Physicians
John W. Mellors spends much of his time researching Virology, Immunology, Acquired immunodeficiency syndrome, Viral load and Viremia. The concepts of his Virology study are interwoven with issues in Reverse transcriptase and Genotype. John W. Mellors has included themes like Drug, MEDLINE and Antiretroviral therapy in his Immunology study.
His work deals with themes such as Viral disease, Clinical research, Drug resistance and Intensive care medicine, which intersect with Acquired immunodeficiency syndrome. His work is dedicated to discovering how Viral load, Internal medicine are connected with Gastroenterology, Reverse-transcriptase inhibitor and Oncology and other disciplines. The study incorporates disciplines such as RNA and In vivo in addition to Virus.
His primary areas of study are Virology, Immunology, Internal medicine, Virus and Viral load. His biological study spans a wide range of topics, including RNA, Reverse transcriptase and Drug resistance. He focuses mostly in the field of Reverse transcriptase, narrowing it down to matters related to Molecular biology and, in some cases, RNase H.
His Immunology research is multidisciplinary, incorporating perspectives in Acquired immunodeficiency syndrome and Antiretroviral therapy. Efavirenz is closely connected to Reverse-transcriptase inhibitor in his research, which is encompassed under the umbrella topic of Internal medicine. His work in Zidovudine covers topics such as Lamivudine which are related to areas like Indinavir.
John W. Mellors mainly investigates Virology, Antiretroviral therapy, Internal medicine, Viremia and RNA. His Virology study focuses on Virus in particular. His Virus research integrates issues from T cell, Monoclonal antibody and Drug resistance.
His Antiretroviral therapy study combines topics from a wide range of disciplines, such as Proviral dna and Viral load. John W. Mellors has researched Internal medicine in several fields, including HIV drug resistance, Acquired immunodeficiency syndrome and Oncology. In his research on the topic of Cohort, Cytotoxic T cell is strongly related with Immunology.
His primary scientific interests are in Virology, Antiretroviral therapy, Viral load, Virus and RNA. His Virology research includes themes of Antibody, Glycoprotein and Provirus. His Viral load study incorporates themes from Viral suppression, Regimen, Lamivudine, Emtricitabine and Pediatrics.
His research in Lamivudine tackles topics such as Raltegravir which are related to areas like Internal medicine. His Emtricitabine research focuses on subjects like Young adult, which are linked to Cohort, Immunology, Clinical trial and Acquired immunodeficiency syndrome. The Virus study combines topics in areas such as Peripheral blood mononuclear cell, Art initiation and Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
John W. Mellors;Alvaro Munoz;Janis V. Giorgi;Joseph B. Margolick.
Annals of Internal Medicine (1997)
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
R M Gulick;J W Mellors;D Havlir;J J Eron.
The New England Journal of Medicine (1997)
HIV sequence compendium 2002
Carla Kuiken;Brian Foley;Eric Freed;Beatrice Hahn.
Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel
Martin S. Hirsch;Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer.
Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
Martin S. Hirsch;Brian Conway;Richard T. D'Aquila;Victoria A. Johnson.
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway.
Clinical Infectious Diseases (2003)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer;Frank Maldarelli;Ann Wiegand;Barry Bernstein.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
F. Maldarelli;X. Wu;L. Su;F. R. Simonetti.
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Ginger Lehrman;Ian B Hogue;Sarah Palmer;Cheryl Jennings.
The Lancet (2005)
Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel
Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Françoise Brun Vézinet.
Clinical Infectious Diseases (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: